Table 1 Demographic data of tumor and tumor-like lesions (N=117 lesions)
Variable | Total (n=117) | Bone lesions (n=51) | Soft tissue lesions (n=66) |
|---|---|---|---|
Mean Age (y) [range, median] | 33.7 [1-86, 31] | 25.2 [9-71, 20] | 40.3 [1-86, 41] |
Sex (Male, Female) | 55 (47%), 62 (53%) | 30 (59%), 21 (41%) | 25 (38%), 41 (62%) |
Follow-up duration (m) [range, median] | 22.2 [1-144, 10] | 22.9 [1-120, 12] | 21.7 [1-144, 8] |
Anatomical location | |||
Hallux | 13 (11%) | 7 (14%) | 6 (9%) |
Lesser toe | 55 (47%) | 20 (39%) | 35 (53%) |
Midfoot | 5 (4%) | 3 (6%) | 2 (3%) |
Hindfoot and ankle | 44 (38%) | 21 (41%) | 23 (35%) |
Size (mm) [range, median] | 23.5 [3-88, 19] | 19.3 [3-58, 15] | 26.8 [5-88, 23.5] |
Surgery procedures | Marginal excision: 15 (29%) | Marginal excision: 57 (86%) | |
Wide excision: 5 (10%) | Wide excision: 4 (6%) | ||
Curettage: 30 (59%) | Amputation: 4 (6%) | ||
Amputation: 1 (2%) | Intratumoral excision: 1 (2%) | ||
Recurrence | 10 (9%) | 4 (8%) | 6 (9%) |
Complications | 7 (6%) | Wound problem: 2 (4%) | Wound problem: 3 (5%) |
Fracture: 2 (4%) | |||
Benign lesion | 102 (87%) | Total: 45 (88%) | Total: 57 (86%) |
Osteochondroma: 11 | TGCT: 22 :11 (22%) | ||
Enchondroma: 9 | Fibroma of tendon sheath: 7 | ||
Solitary bone cyst: 8 | Lipoma: 7 | ||
Chondroblastoma: 4 | Epidermoid cyst: 5 | ||
Osteoid osteoma: 4 | Ganglion:4 | ||
Lipoma: 3 | Angioleiomyoma: 3 | ||
Chondrofibroma: 2 | Hemangioma:3 | ||
Ganglion: 2 | Schwannoma: 3 | ||
Others: 2 | Others: 3 | ||
Intermediate malignancy | 3 (3%) | Total: 1 (2%) | Total: 2 (3%) |
Desmoplastic fibroma: 1 | Desmoid: 1 | ||
Synovial chondromatosis with Cytological atypica: 1 | |||
Malignant lesion | 12 (10%) | Total: 5 (10%) | Total: 7 (11%) |
Leiomyosarcoma:2 | Synovial sarcoma: 2 | ||
Osteosarcoma: 2 | Alveolar rhabdomyosarcoma:1 | ||
Metastasis:1 | Alveolar soft part sarcoma:1 | ||
Atypical fibrous histiocytoma:1 | |||
Leiomyosarcoma:1 | |||
Myxoinflammatory fibroblastic sarcoma: 1 | |||